Headlines about Acadia Healthcare (NASDAQ:ACHC) have been trending somewhat positive on Monday, Accern reports. Accern ranks the sentiment of media coverage by reviewing more than 20 million news and blog sources in real-time. Accern ranks coverage of public companies on a scale of negative one to one, with scores nearest to one being the most favorable. Acadia Healthcare earned a media sentiment score of 0.05 on Accern’s scale. Accern also gave headlines about the company an impact score of 46.8174454318505 out of 100, indicating that recent media coverage is somewhat unlikely to have an effect on the stock’s share price in the next few days.

Here are some of the news headlines that may have effected Accern’s analysis:

A number of analysts recently issued reports on the company. Credit Suisse Group assumed coverage on Acadia Healthcare in a research note on Thursday, November 2nd. They set a “neutral” rating and a $35.00 target price for the company. Mizuho reissued a “neutral” rating on shares of Acadia Healthcare in a research note on Monday, October 30th. BMO Capital Markets lowered their target price on Acadia Healthcare from $52.00 to $48.00 and set an “outperform” rating for the company in a research note on Thursday, October 26th. Craig Hallum reaffirmed a “buy” rating and set a $41.00 price target (down from $65.00) on shares of Acadia Healthcare in a research note on Thursday, October 26th. Finally, Jefferies Group LLC set a $42.00 price target on shares of Acadia Healthcare and gave the stock a “buy” rating in a research note on Wednesday, October 25th. Two equities research analysts have rated the stock with a sell rating, six have issued a hold rating and nine have issued a buy rating to the stock. The company presently has a consensus rating of “Hold” and an average price target of $45.15.

Shares of Acadia Healthcare (ACHC) traded down $0.83 during trading on Monday, reaching $29.01. The company’s stock had a trading volume of 1,363,798 shares, compared to its average volume of 1,353,132. Acadia Healthcare has a fifty-two week low of $26.92 and a fifty-two week high of $54.34. The firm has a market cap of $2,620.00, a P/E ratio of 13.03, a price-to-earnings-growth ratio of 1.11 and a beta of 0.89. The company has a quick ratio of 1.36, a current ratio of 1.36 and a debt-to-equity ratio of 1.30.

Acadia Healthcare (NASDAQ:ACHC) last announced its quarterly earnings results on Tuesday, October 24th. The company reported $0.58 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.65 by ($0.07). Acadia Healthcare had a net margin of 6.07% and a return on equity of 8.57%. The business had revenue of $716.70 million for the quarter, compared to analyst estimates of $728.86 million. During the same period in the prior year, the business earned $0.58 EPS. The company’s revenue for the quarter was down 2.4% compared to the same quarter last year. sell-side analysts expect that Acadia Healthcare will post 2.23 EPS for the current year.

In other news, COO Ronald Morgan Fincher sold 80,000 shares of Acadia Healthcare stock in a transaction on Tuesday, August 22nd. The stock was sold at an average price of $50.69, for a total transaction of $4,055,200.00. Following the completion of the sale, the chief operating officer now owns 59,071 shares of the company’s stock, valued at $2,994,308.99. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Also, President Brent Turner sold 206,252 shares of Acadia Healthcare stock in a transaction on Tuesday, August 22nd. The stock was sold at an average price of $50.69, for a total value of $10,454,913.88. Following the sale, the president now directly owns 81,106 shares of the company’s stock, valued at approximately $4,111,263.14. The disclosure for this sale can be found here. Insiders have sold a total of 1,824,040 shares of company stock valued at $92,460,588 in the last ninety days. Insiders own 11.10% of the company’s stock.

TRADEMARK VIOLATION WARNING: “Acadia Healthcare (ACHC) Getting Somewhat Positive Media Coverage, Study Finds” was originally posted by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are accessing this piece on another publication, it was illegally copied and republished in violation of U.S. and international trademark & copyright law. The legal version of this piece can be viewed at https://www.thecerbatgem.com/2017/11/20/acadia-healthcare-achc-getting-somewhat-positive-media-coverage-study-finds.html.

Acadia Healthcare Company Profile

Acadia Healthcare Company, Inc is a provider of behavioral healthcare services, with operations in the United States and the United Kingdom. The Company focuses on acquiring and developing behavioral healthcare facilities. The Company operates through two segments: U.S. Facilities and U.K. Facilities.

Insider Buying and Selling by Quarter for Acadia Healthcare (NASDAQ:ACHC)

Receive News & Stock Ratings for Acadia Healthcare Company Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acadia Healthcare Company Inc. and related stocks with our FREE daily email newsletter.